Susquehanna Fundamental Investments, LLC Biocryst Pharmaceuticals Inc Transaction History
Susquehanna Fundamental Investments, LLC
- $6.94 Billion
- Q1 2025
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 96,288 shares of BCRX stock, worth $998,506. This represents 0.01% of its overall portfolio holdings.
Number of Shares
96,288
Previous 88,854
8.37%
Holding current value
$998,506
Previous $668,000
8.08%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BCRX
# of Institutions
292Shares Held
176MCall Options Held
721KPut Options Held
489K-
Vanguard Group Inc Valley Forge, PA21.7MShares$225 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$207 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.93MShares$92.6 Million5.64% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.7MShares$90.2 Million1.06% of portfolio
-
State Street Corp Boston, MA7.81MShares$81 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.93B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...